Inhibitory purinergic P2 receptor characterisation in rat distal colon

• Published in: Neuropharmacology 2007-08, Vol.53 (2), p.257-271
• Main Authors: Van Crombruggen, K., Van Nassauw, L., Timmermans, J.-P., Lefebvre, R.A.
• Format: Article
• Language: English
• Subjects: Adenosine Diphosphate - analogs & derivatives; Adenosine Diphosphate - pharmacology; Adenosine Triphosphate - analogs & derivatives; Adenosine Triphosphate - pharmacology; Anesthetics, Local - pharmacology; Animals; Colon - cytology; Dose-Response Relationship, Drug; Drug Interactions; Functional study; Immunocytochemistry; In Vitro Techniques; Male; Methacholine Chloride - pharmacology; Muscarinic Agonists - pharmacology; Muscle Relaxation - drug effects; Muscle, Smooth - drug effects; Muscle, Smooth - physiology; Muscular; Nerve Tissue Proteins - metabolism; Neuronal; NG-Nitroarginine Methyl Ester - pharmacology; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic receptors; Rat distal colon motility; Rats; Rats, Wistar; Receptors, Purinergic P1 - classification; Receptors, Purinergic P1 - physiology; Tetrodotoxin - pharmacology; Thionucleotides - pharmacology
• ISSN: 0028-3908; 1873-7064
• DOI: 10.1016/j.neuropharm.2007.05.010

The aim of this study was to characterise the P2 receptors involved in purinergic relaxant responses in rat distal colon circular muscle. Concentration–response curves for purinergic agonists were constructed on methacholine-precontracted circular muscle strips of rat distal colon in the absence and presence of the nerve blocker TTX and the ecto-nucleotidase inhibitor ARL67156. The effects of the P2 receptor antagonists RB2, PPADS, suramin, MRS2179 and NF279, the NO-synthase inhibitor L-NAME and the small conductance K + channel blocker apamin were investigated. The localisation of the different P2 receptors was examined immunocytochemically. Immunocytochemistry demonstrated the expression of P2Y 1, P2Y 6 and P2X 1 receptors on smooth muscle cells and P2Y 2, P2Y 12, P2X 2 and P2X 3 receptors in the myenteric plexus; almost a quarter of the P2Y 2-immunopositive neurons co-expressed nNOS. The P2X-selective agonist αβmeATP and the P2Y-selective agonist ADPβS were the most potent relaxants; their effects were abolished by apamin. The effect of ADPβS was antagonised by the P2Y 1-selective antagonist MRS2179 pointing to interaction with the muscular P2Y 1-receptors. The relaxant effect of αβmeATP was partially reduced by TTX and concentration-dependently antagonised by PPADS, suramin, RB2 and the P2X 1-selective antagonist NF279; this correlates with an interaction with neuronal P2X 3 and muscular P2X 1 receptors. UTP was the least potent agonist; its effect was markedly increased by ARL67156, nearly abolished by TTX and reduced by L-NAME. This points to interaction with the neuronal P2Y 2-receptors inducing relaxation, at least partially, by NO release.